Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FP8J0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,921
Award facts
- Contract value 100% obligated
- $14,920.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,920.95 for Dupixent (dupilumab) 200 mg/1.14 mL pen auto-injectors on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves supply of this biologic immunosuppressant medication, which is commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other allergic inflammatory conditions within the Defense Health System.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total potential value of $999,999,999.00 through December 2026. This prime pharmaceutical vendor contract serves as a comprehensive global supply vehicle enabling AmerisourceBergen to deliver a broad range of brand-name and generic pharmaceuticals, specialty medications, and medical supplies to support military healthcare programs and the Defense Health Agency. The company's IDC demonstrates its capability to meet federal pharmaceutical procurement requirements through competitive contracting, supporting critical medical needs across the military health system and related government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FP8J0?
SPE2DB25FP8J0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FP8J0 worth?
The government has obligated $14,921 on SPE2DB25FP8J0.
Is contract SPE2DB25FP8J0 an order under another contract?
Yes. SPE2DB25FP8J0 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP8J0 competed?
The extent of competition for SPE2DB25FP8J0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award